EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-1.24%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$5.05B
AUM Growth
+$28.3M
(+0.56%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
3.25%
Top 10 Holdings %
Top 10 Hldgs %
19.52%
Holding
911
New
26
Increased
159
Reduced
108
Closed
21
Top Buys
| 1 |
Victoria's Secret
VSCO
|
+$33.2M |
| 2 |
Moderna
MRNA
|
+$22.6M |
| 3 |
Marsh & McLennan
MMC
|
+$19.8M |
| 4 |
Automatic Data Processing
ADP
|
+$19.3M |
| 5 |
Costco
COST
|
+$16.6M |
Top Sells
| 1 |
Oracle
ORCL
|
+$19.8M |
| 2 |
Bath & Body Works
BBWI
|
+$18.2M |
| 3 |
Ametek
AME
|
+$13.5M |
| 4 |
NextEra Energy, Inc.
NEE
|
+$12.7M |
| 5 |
Signet Jewelers
SIG
|
+$11.8M |
Sector Composition
| 1 | Technology | 29.95% |
| 2 | Healthcare | 19.46% |
| 3 | Consumer Discretionary | 13.98% |
| 4 | Financials | 9.64% |
| 5 | Industrials | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Vir Biotechnology
VIR
$728M
| $1.44M | 0.03% |
33,300
| – | – |
|
302
Enbridge
ENB
$105B
| $1.43M | 0.03% |
35,700
| – | – |
|
|
GBT
303
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.38M | 0.03% |
53,500
| – | – |
|
304
Intellia Therapeutics
NTLA
$1.28B
| $1.35M | 0.03% |
9,800
| – | – |
|
305
American Express
AXP
$226B
| $1.35M | 0.03% |
7,844
-1,264
| -14% | -$217K |
|
306
Kodiak Sciences
KOD
$531M
| $1.34M | 0.03% |
13,700
| – | – |
|
307
Beam Therapeutics
BEAM
$2.06B
| $1.31M | 0.03% |
15,000
+8,500
| +131% | +$742K |
|
308
Aflac
AFL
$56.8B
| $1.29M | 0.03% |
24,500
| – | – |
|
309
DocuSign
DOCU
$16B
| $1.28M | 0.03% |
5,000
| – | – |
|
310
Amicus Therapeutics
FOLD
$2.43B
| $1.28M | 0.03% |
132,000
| – | – |
|
|
TPTX
311
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $1.27M | 0.03% |
18,700
| – | – |
|
|
JNPR
312
DELISTED
Juniper Networks
JNPR
| $1.25M | 0.02% |
44,200
| – | – |
|
313
Insmed
INSM
$31.1B
| $1.25M | 0.02% |
47,600
| – | – |
|
314
Tenaris
TS
$18.3B
| $1.24M | 0.02% |
60,000
| – | – |
|
315
CDW
CDW
$22.1B
| $1.23M | 0.02% |
6,783
-47,798
| -88% | -$8.7M |
|
316
Berkshire Hathaway Class A
BRK.A
$1.06T
| $1.23M | 0.02% |
3
| – | – |
|
317
Cadence Design Systems
CDNS
$98.6B
| $1.22M | 0.02% |
8,000
| – | – |
|
318
Skyworks Solutions
SWKS
$11.1B
| $1.2M | 0.02% |
7,272
+1,484
| +26% | +$245K |
|
319
Zai Lab
ZLAB
$3.5B
| $1.17M | 0.02% |
10,900
| – | – |
|
320
Philip Morris
PM
$256B
| $1.16M | 0.02% |
12,084
+178
| +1% | +$17.1K |
|
321
Adaptive Biotechnologies
ADPT
$1.92B
| $1.16M | 0.02% |
35,700
| – | – |
|
322
Aaon
AAON
$6.37B
| $1.14M | 0.02% |
26,258
-169,794
| -87% | -$7.4M |
|
|
SPLK
323
DELISTED
Splunk Inc
SPLK
| $1.1M | 0.02% |
8,000
| – | – |
|
324
Kura Oncology
KURA
$695M
| $1.09M | 0.02% |
58,000
| – | – |
|
325
iShares MSCI ACWI ETF
ACWI
$22.3B
| $1.07M | 0.02% |
10,737
-11,321
| -51% | -$1.13M |
|